Alba Atienza Párraga

Genome-wide profiling of histone H3 lysine 27 and lysine 4 trimethylation in multiple myeloma reveals the importance of Polycomb gene targeting and highlights EZH2 as a potential therapeutic target

Prasoon Agarwal, Mohammad Alzrigat, Alba Atienza Párraga et al. · Oncotarget · 2016 · 71 citations · Full text

EZH2 inhibition in multiple myeloma downregulates myeloma associated oncogenes and upregulates microRNAs with potential tumor suppressor functions

Mohammad Alzrigat, Alba Atienza Párraga, Prasoon Agarwal et al. · Oncotarget · 2016 · 53 citations · Full text

Ezh2 Inhibition, Tumor Biology, Hematological Malignancy +14

The polycomb group protein BMI-1 inhibitor PTC-209 is a potent anti-myeloma agent alone or in combination with epigenetic inhibitors targeting EZH2 and the BET bromodomains

Mohammad Alzrigat, Alba Atienza Párraga, Muntasir Mamun Majumder et al. · Oncotarget · 2017 · 25 citations · Full text

A distinct metabolic response characterizes sensitivity to EZH2 inhibition in multiple myeloma

Patrick Nylund, Alba Atienza Párraga, Jakob Haglöf et al. · Cell Death and Disease · 2021 · 21 citations · Full text

<i>PVT1</i> interacts with polycomb repressive complex 2 to suppress genomic regions with pro-apoptotic and tumour suppressor functions in multiple myeloma

Patrick Nylund, Berta Garrido-Zabala, Alba Atienza Párraga et al. · Haematologica · 2023 · 11 citations · Full text